Susceptibility and response of human blood monocyte subsets to primary dengue virus infection

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Wong, Kok Loon ^a   Chen, Weiqiang ^a   Balakrishnan, Thavamalar ^a   Toh, Ying Xiu ^a   Fink, Katja ^a   Wong, Siew Cheng ^a  

^a AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; FC RECEPTOR; INTERLEUKIN 4;

ARTICLE; CD16+ MONOCYTE; CD16- MONOCYTE; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENGUE; DENGUE VIRUS; DENGUE VIRUS 2; HUMAN; HUMAN CELL; IN VITRO STUDY; INFECTION SENSITIVITY; LEUKOCYTE FUNCTION; MONOCYTE; PATHOGENESIS; PROTECTION; VIRUS PARTICLE; BIOSYNTHESIS; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SOLUBILITY; VIROLOGY;

DENGUE VIRUS;

CELL SURVIVAL; CHEMOKINES; DENGUE VIRUS; HUMANS; INTERLEUKIN-4; MONOCYTES; RECEPTORS, IGG; SOLUBILITY;

EID: 84860536610     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036435     Document Type: Article

References (68)

1. Ziegler Heitbrock HW, (1996) Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. Immunol. Today 17: 424-428.
2. Passlick B, Flieger D, Ziegler Heitbrock HW, (1989) Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74: 2527-2534.
3. Frankenberger M, Sternsdorf T, Pechumer H, Pforte A, Ziegler Heitbrock HW, (1996) Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood 87: 373-377.
4. Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, et al. (2002) The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J. Immunol. 168: 3536-3542.
5. Weber C, Belge KU, von HP, Draude G, Steppich B, et al. (2000) Differential chemokine receptor expression and function in human monocyte subpopulations. J. Leukoc. Biol. 67: 699-704.
6. Geissmann F, Jung S, Littman DR, (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 19: 71-82.
7. Auffray C, Fogg D, Garfa M, Elain G, Join Lambert O, et al. (2007) Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317: 666-670.
8. Ancuta P, Rao R, Moses A, Mehle A, Shaw SK, et al. (2003) Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J. Exp. Med. 197: 1701-1707.
9. Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, et al. (2010) Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity. 33: 375-386.
10. Ziegler Heitbrock L, (2007) The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J. Leukoc. Biol. 81: 584-592.
11. Ellery PJ, Tippett E, Chiu YL, Paukovics G, Cameron PU, et al. (2007) The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J. Immunol. 178: 6581-6589.
12. Mackenzie JS, Gubler DJ, Petersen LR, (2004) Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10: S98-109.
13. Henchal EA, Putnak JR, (1990) The dengue viruses. Clin. Microbiol. Rev. 3: 376-396.
14. Balmaseda A, Hammond SN, Tellez Y, Imhoff L, Rodriguez Y, et al. (2006) High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop. Med. Int. Health 11: 935-942.
15. Burke DS, Nisalak A, Johnson DE, Scott RM, (1988) A prospective study of dengue infections in Bangkok. Am. J. Trop. Med. Hyg. 38: 172-180.
16. Endy TP, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, et al. (2002) Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am. J. Epidemiol. 156: 40-51.
17. Thein S, Aung MM, Shwe TN, Aye M, Zaw A, et al. (1997) Risk factors in dengue shock syndrome. Am. J. Trop. Med. Hyg. 56: 566-572.
18. Halstead SB, (2007) Dengue. Lancet 370: 1644-1652.
19. Gubler DJ, (1998) Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 11: 480-496.
20. Kyle JL, Harris E, (2008) Global spread and persistence of dengue. Annu. Rev. Microbiol. 62: 71-92.
21. Durbin AP, Vargas MJ, Wanionek K, Hammond SN, Gordon A, et al. (2008) Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology 376: 429-435.
22. Jessie K, Fong MY, Devi S, Lam SK, Wong KT, (2004) Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J. Infect. Dis. 189: 1411-1418.
23. Kurane I, Ennis FA, (1988) Production of interferon alpha by dengue virus-infected human monocytes. J. Gen. Virol. 69 (Pt 2): 445-449.
24. Fink K, Ng C, Nkenfou C, Vasudevan SG, van RN, et al. (2009) Depletion of macrophages in mice results in higher dengue virus titers and highlights the role of macrophages for virus control. Eur. J. Immunol. 39: 2809-2821.
25. Halstead SB, O'Rourke EJ, Allison AC, (1977) Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J. Exp. Med. 146: 218-229.
26. Kou Z, Quinn M, Chen H, Rodrigo WW, Rose RC, et al. (2008) Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. J. Med. Virol. 80: 134-146.
27. Halstead SB, (1988) Pathogenesis of dengue: challenges to molecular biology. Science 239: 476-481.
28. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS, (1989) Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40: 444-451.
29. Bosch I, Xhaja K, Estevez L, Raines G, Melichar H, et al. (2002) Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J. Virol. 76: 5588-5597.
30. Carr JM, Hocking H, Bunting K, Wright PJ, Davidson A, et al. (2003) Supernatants from dengue virus type-2 infected macrophages induce permeability changes in endothelial cell monolayers. J. Med. Virol. 69: 521-528.
31. Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, et al. (2008) CLEC5A is critical for dengue-virus-induced lethal disease. Nature 453: 672-676.
32. Chen YC, Wang SY, (2002) Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide. J. Virol. 76: 9877-9887.
33. Spain Santana TA, Marglin S, Ennis FA, Rothman AL, (2001) MIP-1 alpha and MIP-1 beta induction by dengue virus. J. Med. Virol. 65: 324-330.
34. Azeredo EL, Neves-Souza PC, Alvarenga AR, Reis SR, Torrentes-Carvalho A, et al. (2010) Differential regulation of toll-like receptor-2, toll-like receptor-4, CD16 and human leucocyte antigen-DR on peripheral blood monocytes during mild and severe dengue fever. Immunology 130: 202-216.
35. Mustafa AS, Elbishbishi EA, Agarwal R, Chaturvedi UC, (2001) Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunol. Med. Microbiol. 30: 229-233.
36. Devignot S, Sapet C, Duong V, Bergon A, Rihet P, et al. (2010) Genome-wide expression profiling deciphers host responses altered during dengue shock syndrome and reveals the role of innate immunity in severe dengue. PLoS. One. 5: e11671.
37. Miller JL, de Wet BJ, Martinez-Pomares L, Radcliffe CM, Dwek RA, et al. (2008) The mannose receptor mediates dengue virus infection of macrophages. PLoS. Pathog. 4: e17.
38. Tassaneetrithep B, Burgess TH, Granelli Piperno A, Trumpfheller C, Finke J, et al. (2003) DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197: 823-829.
39. Mukhopadhyay S, Kuhn RJ, Rossmann MG, (2005) A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 3: 13-22.
40. Chen JP, Lu HL, Lai SL, Campanella GS, Sung JM, et al. (2006) Dengue virus induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate. J. Immunol. 177: 3185-3192.
41. Ip PP, Liao F, (2010) Resistance to dengue virus infection in mice is potentiated by CXCL10 and is independent of CXCL10-mediated leukocyte recruitment. J. Immunol. 184: 5705-5714.
42. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD, (1998) How cells respond to interferons. Annu. Rev. Biochem. 67: 227-264.
43. Diamond MS, Roberts TG, Edgil D, Lu B, Ernst J, et al. (2000) Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J. Virol. 74: 4957-4966.
44. Warke RV, Martin KJ, Giaya K, Shaw SK, Rothman AL, et al. (2008) TRAIL is a novel antiviral protein against dengue virus. J. Virol. 82: 555-564.
45. Fahy RJ, Doseff AI, Wewers MD, (1999) Spontaneous human monocyte apoptosis utilizes a caspase-3-dependent pathway that is blocked by endotoxin and is independent of caspase-1. J. Immunol. 163: 1755-1762.
46. Mangan DF, Welch GR, Wahl SM, (1991) Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J. Immunol. 146: 1541-1546.
47. Mangan DF, Wahl SM, (1991) Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J. Immunol. 147: 3408-3412.
48. Campbell JJ, Qin S, Unutmaz D, Soler D, Murphy KE, et al. (2001) Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J. Immunol. 166: 6477-6482.
49. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, et al. (1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest 101: 746-754.
50. Kumar Sinha C, Varambally S, Sreekumar A, Chinnaiyan AM, (2002) Molecular cross-talk between the TRAIL and interferon signaling pathways. J. Biol. Chem. 277: 575-585.
51. Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, et al. (2002) The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J. Immunol. 168: 3536-3542.
52. Frankenberger M, Sternsdorf T, Pechumer H, Pforte A, Ziegler Heitbrock HW, (1996) Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood 87: 373-377.
53. Dewi BE, Takasaki T, Kurane I, (2004) In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. J. Virol. Methods 121: 171-180.
54. Yen YT, Chen HC, Lin YD, Shieh CC, Wu Hsieh BA, (2008) Enhancement by tumor necrosis factor alpha of dengue virus-induced endothelial cell production of reactive nitrogen and oxygen species is key to hemorrhage development. J. Virol. 82: 12312-12324.
55. Fernandez Mestre MT, Gendzekhadze K, Rivas Vetencourt P, Layrisse Z, (2004) TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens 64: 469-472.
56. Hober D, Poli L, Roblin B, Gestas P, Chungue E, et al. (1993) Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am. J. Trop. Med. Hyg. 48: 324-331.
57. Wang L, Chen RF, Liu JW, Yu HR, Kuo HC, et al. (2007) Implications of dynamic changes among tumor necrosis factor-alpha (TNF-alpha), membrane TNF receptor, and soluble TNF receptor levels in regard to the severity of dengue infection. Am. J. Trop. Med. Hyg. 77: 297-302.
58. Lee YR, Liu MT, Lei HY, Liu CC, Wu JM, et al. (2006) MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J. Gen. Virol. 87: 3623-3630.
59. Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, et al. (2008) Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC. Infect. Dis. 8: 86.
60. Fahy RJ, Doseff AI, Wewers MD, (1999) Spontaneous human monocyte apoptosis utilizes a caspase-3-dependent pathway that is blocked by endotoxin and is independent of caspase-1. J. Immunol. 163: 1755-1762.
61. Mangan DF, Wahl SM, (1991) Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J. Immunol. 147: 3408-3412.
62. Mangan DF, Welch GR, Wahl SM, (1991) Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J. Immunol. 146: 1541-1546.
63. McLean JE, Wudzinska A, Datan E, Quaglino D, Zakeri Z, (2011) Flavivirus NS4A-induced Autophagy Protects Cells against Death and Enhances Virus Replication. J. Biol. Chem. 286: 22147-22159.
64. Lyons PA, Koukoulaki M, Hatton A, Doggett K, Woffendin HB, et al. (2007) Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification. BMC. Genomics 8: 64.
65. Azeredo EL, Neves-Souza PC, Alvarenga AR, Reis SR, Torrentes Carvalho A, et al. (2010) Differential regulation of toll-like receptor-2, toll-like receptor-4, CD16 and human leucocyte antigen-DR on peripheral blood monocytes during mild and severe dengue fever. Immunology 130: 202-216.
66. Wong KL, Tai JJ, Wong WC, Han H, Sem X, et al. (2011) Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 118: e16-e31.
67. Zawada AM, Rogacev KS, Rotter B, Winter P, Marell RR, et al. (2011) SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood.
68. Ziegler Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, et al. (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116: e74-e80.